I just want to know that Patients and Healthcare Systems are able to provide access outside of a Clinical Trial/Compassionate Use setting. Hopefully Mayo and a few other Phase III Sites are taking advantage of Compassionate Use and providing to thier Patients now, but that process can be time consuming and convoluted when your working against the clock to properly administer, and it still has a level of Patients fears to overcome. It is frustrating wondering how many people may have needed Lenzilumab, but did not get it this far into the Pandemic.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.